TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has provided an announcement.
Clarity Pharmaceuticals Ltd has announced the quotation of 95,622 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code CU6, effective from November 10, 2025. This move is part of the company’s strategic efforts to enhance its market presence and provide liquidity to its shareholders, potentially strengthening its position in the radiopharmaceutical sector.
The most recent analyst rating on (AU:CU6) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd operates in the pharmaceutical industry, focusing on the development and commercialization of radiopharmaceuticals for the treatment of serious diseases. The company is known for its innovative approach in targeting specific cancer types using its proprietary technology.
Average Trading Volume: 2,959,118
Technical Sentiment Signal: Buy
Current Market Cap: A$1.69B
See more data about CU6 stock on TipRanks’ Stock Analysis page.